Companies: 10,795·Total market cap: $144.5T
CollPlant Biotechnologies Ltd.

CollPlant Biotechnologies Ltd.

CLGNNASDAQHealthcare● Active
$0.37
$-0.00(-0.27%)
Market Cap$4522010
P/E Ratio
52W High$3.232
52W Low$0.271

CollPlant Biotechnologies Ltd. (CLGN) Stock Ownership

Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.

SEC 13F · FMP · CLGN · as of Sep 30, 2025

Ownership Breakdown

Institutions 0.03%
Insiders 17.03%
Public 82.94%

1

Institutional Holders

$8,752

Total Inst. Value

▲ $4,327 vs Q2

12.22M

Shares Outstanding

freeFloat 82.97%

3,253

13F Shares Held

▼ 1 vs Q2

Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.

Top Institutional Holders

CLGN largest shareholders · institutional ownership

Q3 2025 · SEC 13F

Showing top 1 holders

HolderShares% OwnedWeightValueReportedChange

PARALLEL ADVISORS, LLC

orthopedic, prosthetic & surgical appliances & supplies

3.3K2.75%

2.75%

$8.75MNov 13, 2025 1

Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).

Institutional Activity

Q3 2025 vs prior quarter

Q3 2025

Net institutional sentimentBearish — more selling than buying

0

Increased

+0 shares

0

New Positions

first time holders

1

Decreased

−1 shares

0

Sold Out

fully exited

Net shares change (top 50)

1

+0 / −1

Net new holders

-1

0 new / 0 exited

Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).

Insider Buying vs Selling

CLGN insider trading · insider activity

Source: SEC Form 4

0

Buy transactions

0

Sell transactions

0.00

Buy/Sell ratio

$0M

Total disposed

Recent Insider Transactions

Showing 10 most recent · Common Stock only

No recent insider transactions reported.

Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.

About institutional & insider ownership

CollPlant Biotechnologies Ltd. (CLGN) is primarily owned by institutional investors, who hold approximately 0.0% of total shares outstanding. Company insiders own approximately 17.03%, while retail and public investors account for the remaining 82.94%.

The largest institutional shareholder of CollPlant Biotechnologies Ltd. is PARALLEL ADVISORS, LLC, holding approximately 3,253 shares — equal to 2.75% of outstanding shares — as of September 30, 2025.

A total of 1 institutional investors currently hold CLGN stock, with a combined institutional value of approximately $8,752 as of the most recent 13F filing period.

Frequently asked questions

CLGN ownership

CollPlant Biotechnologies Ltd. (CLGN) is primarily owned by institutional investors, who hold approximately 0.0% of shares. The largest shareholder is PARALLEL ADVISORS, LLC with a 2.75% stake. Company insiders hold 17.03%. Data sourced from SEC Form 13F as of September 30, 2025.

who owns CLGN stockCLGN ownership structureSEC Form 13F institutional holdingsCLGN float vs institutions
Source: FMP · SEC Form 13F · SEC Form 4As of September 30, 2025